Loading…
Hyderabad-based multi-specialty hospital chain expanding across south and east India.
Hyderabad-based multi-specialty hospital chain expanding across south and east India.
Bills patients, insurers and state health schemes per treatment and occupied bed, so earnings follow beds, occupancy and revenue per bed, and a new hospital takes time to fill. Aarogyasri, a state insurance scheme in Telangana, is a significant payer. It has expanded outside its home base by building and buying hospitals.
Moat: narrow (brand, installed base). Strong regional brand and bed capacity in Telangana/Andhra Pradesh with expansion into new states.
Headquarters: Hyderabad, India · Founded: 1973 · Employees: 18,491
Size Krishna Institute of Medical Sciences (KIMS.NS) is an India Health Care company (Hospital/Nursing Management) with a market value of $3.21B, the 275th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹723.00 on 6 Nov 2026.
Performance Over six months the shares gained 2.3%, against -1.7% for the median peer and 0.0% for the India market (cap-weighted) — 10th highest of 21 in its peer set.
Growth Revenue grew 30.9% over the last twelve months (peer median +9.1%); the operating margin is 11.9% (peer median 10.7%).
Valuation It trades at 70.0× forward earnings against a peer median of 37.3× (4th most expensive of 19).
Capital Return on invested capital runs 5.7 points below its cost of capital (12.0% WACC).
Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹42.1B | ₹39.0B | ₹30.4B | ₹25.0B | ₹22.0B |
| Revenue growth | — | +29% | +21% | +14% | — |
| Gross profit | ₹22.7B | ₹9.04B | ₹9.10B | ₹7.37B | ₹6.99B |
| EBITDA | ₹8.33B | ₹8.26B | ₹8.07B | ₹6.57B | ₹6.18B |
| Net income | ₹2.04B | ₹2.41B | ₹3.85B | ₹3.10B | ₹3.36B |
| Free cash flow | n/a | -₹11.1B | -₹5.42B | -₹1.84B | -₹1.51B |
| Capital expenditure | n/a | ₹14.3B | ₹10.1B | ₹6.47B | ₹5.75B |
| Total debt | n/a | ₹42.4B | ₹25.6B | ₹13.6B | ₹6.78B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Krishna Institute of Medical Sciences KIMS.NS | $3.21B | +2% | +31% | 12% | 70.0× | n/a |
| Global Health MEDANTA.NS | $3.95B | +15% | +26% | 17% | 51.1× | n/a |
| Narayana Hrudayalaya NH.NS | $4.11B | +3% | +71% | 13% | 36.5× | 31.1% |
| Rainbow Childrens Medicare RAINBOW.NS | $1.34B | -4% | +23% | 22% | 39.4× | 30.2% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | $1.05B | +25% | +50% | 16% | 41.0× | n/a |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | KIMS.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +4.2% | +4.0% | 11th highest of 21 |
| 6-month return | +2.3% | -1.7% | 10th highest of 21 |
| Distance from 52-week high | -15.7% | -17.9% | 10th highest of 21 |
| Revenue growth (TTM) | +30.9% | +9.1% | 3rd highest of 21 |
| Operating margin | 11.9% | 10.7% | 10th highest of 21 |
| Forward P/E | 70.0× | 37.3× | 4th most expensive of 19 |
| ROIC minus cost of capital | -5.7 pp | -1.6 pp | 3rd lowest of 21 |
| EV / EBITDA | 40.6× | 17.6× | 2nd most expensive of 15 |
| Net debt / EBITDA | 5.0× | 2.5× | 7th most indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Krishna Institute of Medical Sciences KIMS.NS | India | $3.21B | +2% | +31% | 12% | 70.0× | n/a | n/a |
| National HealthCare NHC | United States | $3.27B | +11% | +7% | -8% | n/a | 7.9% | +9.7% |
| Surgery Partners SGRY | United States | $2.99B | +61% | +4% | 14% | 62.5× | 13.8% | +12.2% |
| Global Health MEDANTA.NS | India | $3.95B | +15% | +26% | 17% | 51.1× | n/a | n/a |
| Narayana Hrudayalaya NH.NS | India | $4.11B | +3% | +71% | 13% | 36.5× | 31.1% | +25.0% |
| Topchoice Medical 600763.SS | China | $2.51B | -11% | +7% | 26% | 26.7× | 13.6% | +6.9% |
| Ardent Health ARDT | United States | $2.44B | +71% | +3% | 4% | 14.5× | 4.0% | +8.7% |
| Brookdale Senior Living BKD | United States | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% | -1.4% |
| Huaxia Eye Hospital 301267.SZ | China | $1.92B | -16% | +2% | 15% | 24.7× | 3.8% | +10.4% |
| Extendicare EXE.TO | Canada | $1.87B | -9% | +31% | 9% | 19.4× | 11.2% | +8.5% |
| Fortis Healthcare FORTIS.NS | India | $6.13B | -19% | +18% | 17% | 45.0× | 41.0% | +17.9% |
| Sienna Senior Living SIA.TO | Canada | $1.63B | -11% | +16% | 10% | 38.1× | 19.6% | +8.6% |
| Aster DM Quality Care ASTERDM.NS | India | $6.57B | -3% | +16% | 14% | 49.6× | 55.3% | -11.6% |
| Xi'an International Medical Investment 000516.SZ | China | $1.54B | 0% | -1% | -2% | n/a | 13.6% | +20.6% |
| Chemed CHE | United States | $6.87B | +24% | +5% | 14% | 19.5× | 2.4% | +4.0% |
| Aevis Victoria AEVS.SW | Switzerland | $1.49B | +9% | +15% | -6% | 107.9× | 26.6% | +10.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.48B | -21% | +17% | 6% | 148.9× | n/a | n/a |
| Spire Healthcare SPI.L | United Kingdom | $1.34B | +68% | +2% | 8% | 19.5× | 9.8% | +11.4% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.34B | -4% | +23% | 22% | 39.4× | 30.2% | +21.2% |
| PACS PACS | United States | $7.87B | +48% | +11% | 8% | 19.2× | 7.6% | +29.7% |
| Raffles Medical BSL.SI | Singapore | $1.25B | -15% | -3% | 11% | 27.3× | -2.4% | +6.1% |